; (2) subsection (a)(2), includes a specification of actions the Secretary is taking to make additional COVID–19 diagnostic tests available to the local public health agency or health care provider submitting such notification; (3) subsection (a)(3), includes a specification of actions the Secretary is taking to support COVID–19 diagnostic testing at the skilled nursing facility or nursing facility submitting such notification; and (4) subsection (a)(4), includes a specification of actions the Secretary is taking to reduce the time described in such subsection. (c) Definition For purposes of subsection (b), the term specified congressional representatives means, with respect to a notification described in subsection (a), both Members of the Senate representing the State, and all Members of the House of Representatives representing the district (or districts), where, in the case of a notification— (1) described in subsection (a)(1), the facility identified by the health care provider submitting such notification is located; (2) described in subsection (a)(2), the State or local public health agency submitting such notification exercises jurisdiction or where the health care provider practices (as identified by the provider); (3) described in subsection (a)(3), where the State or local public health agency submitting such notification exercises jurisdiction; or (4) described in subsection (a)(4), where the skilled nursing facility or nursing facility submitting such notification is located.